159 related articles for article (PubMed ID: 9050960)
1. Positron emission tomography and magnetic resonance imaging for cerebral involvement in patients with systemic lupus erythematosus.
Sailer M; Burchert W; Ehrenheim C; Smid HG; Haas J; Wildhagen K; Wurster U; Deicher H
J Neurol; 1997 Mar; 244(3):186-93. PubMed ID: 9050960
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET.
Weiner SM; Otte A; Schumacher M; Klein R; Gutfleisch J; Brink I; Otto P; Nitzsche EU; Moser E; Peter HH
Ann Rheum Dis; 2000 May; 59(5):377-85. PubMed ID: 10784521
[TBL] [Abstract][Full Text] [Related]
3. The role of FDG-PET, HMPAO-SPET and MRI in the detection of brain involvement in patients with systemic lupus erythematosus.
Kao CH; Lan JL; ChangLai SP; Liao KK; Yen RF; Chieng PU
Eur J Nucl Med; 1999 Feb; 26(2):129-34. PubMed ID: 9933346
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography in neuropsychiatric lupus erythematosus.
Stoppe G; Wildhagen K; Seidel JW; Meyer GJ; Schober O; Heintz P; Künkel H; Deicher H; Hundeshagen H
Neurology; 1990 Feb; 40(2):304-8. PubMed ID: 2132733
[TBL] [Abstract][Full Text] [Related]
5. [Use of fluorodeoxyglucose PET in the diagnosis of central nervous system lupus erythematosus and a comparison with CT and MRI].
Stoppe G; Wildhagen K; Meyer GJ; Schober O
Nuklearmedizin; 1989 Oct; 28(5):187-92. PubMed ID: 2813082
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging abnormalities and cognitive deficits in systemic lupus erythematosus patients without overt central nervous system disease.
Kozora E; West SG; Kotzin BL; Julian L; Porter S; Bigler E
Arthritis Rheum; 1998 Jan; 41(1):41-7. PubMed ID: 9433868
[TBL] [Abstract][Full Text] [Related]
7. [Cerebral positron emission tomographic study in systemic lupus erythematosus].
Csépány T; Gulyás B; Trón L; Szakáll S; Kiss E; Kollár J; Sikula J; Szegedi G; Csiba L
Orv Hetil; 1997 Aug; 138(31):1947-52. PubMed ID: 9280887
[TBL] [Abstract][Full Text] [Related]
8. Brain glucose utilization in systemic lupus erythematosus with neuropsychiatric symptoms: a controlled positron emission tomography study.
Otte A; Weiner SM; Peter HH; Mueller-Brand J; Goetze M; Moser E; Gutfleisch J; Hoegerle S; Juengling FD; Nitzsche EU
Eur J Nucl Med; 1997 Jul; 24(7):787-91. PubMed ID: 9211766
[TBL] [Abstract][Full Text] [Related]
9. Discrepancy between regional cerebral blood flow and glucose metabolism of the brain in systemic lupus erythematosus patients with normal brain magnetic resonance imaging findings.
Kao CH; Ho YJ; Lan JL; Changlai SP; Liao KK; Chieng PU
Arthritis Rheum; 1999 Jan; 42(1):61-8. PubMed ID: 9920015
[TBL] [Abstract][Full Text] [Related]
10. Neuropsychiatric lupus erythematosus: a 10-year prospective study on the value of diagnostic tests.
West SG; Emlen W; Wener MH; Kotzin BL
Am J Med; 1995 Aug; 99(2):153-63. PubMed ID: 7625420
[TBL] [Abstract][Full Text] [Related]
11. White matter lesions and brain atrophy in systemic lupus erythematosus patients: correlation to cognitive dysfunction in a cohort of systemic lupus erythematosus patients using different definition models for neuropsychiatric systemic lupus erythematosus.
Cannerfelt B; Nystedt J; Jönsen A; Lätt J; van Westen D; Lilja A; Bengtsson A; Nilsson P; Mårtensson J; Sundgren PC
Lupus; 2018 Jun; 27(7):1140-1149. PubMed ID: 29523054
[TBL] [Abstract][Full Text] [Related]
12. Subcortical gray matter atrophy is associated with cognitive deficit in multiple sclerosis but not in systemic lupus erythematosus patients.
Kalinowska-Łyszczarz A; Pawlak MA; Pietrzak A; Pawlak-Buś K; Leszczyński P; Puszczewicz M; Majewski D; Paprzycki W; Kozubski W; Michalak S
Lupus; 2018 Apr; 27(4):610-620. PubMed ID: 28992796
[TBL] [Abstract][Full Text] [Related]
13. Childhood central nervous system lupus; longitudinal assessment using single photon emission computed tomography.
Reiff A; Miller J; Shaham B; Bernstein B; Szer IS
J Rheumatol; 1997 Dec; 24(12):2461-5. PubMed ID: 9415658
[TBL] [Abstract][Full Text] [Related]
14. Fluctuating cognitive abnormalities and cerebral glucose metabolism in neuropsychiatric systemic lupus erythematosus.
Carbotte RM; Denburg SD; Denburg JA; Nahmias C; Garnett ES
J Neurol Neurosurg Psychiatry; 1992 Nov; 55(11):1054-9. PubMed ID: 1469402
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and pathogenesis of CNS lupus.
van Dam AP
Rheumatol Int; 1991; 11(1):1-11. PubMed ID: 1866569
[TBL] [Abstract][Full Text] [Related]
16. Decreased regional cerebral metabolic rate for glucose in systemic lupus erythematosus patients with psychiatric symptoms.
Komatsu N; Kodama K; Yamanouchi N; Okada S; Noda S; Nawata Y; Takabayashi K; Iwamoto I; Saito Y; Uchida Y; Ito H; Yoshikawa K; Sato T
Eur Neurol; 1999 Jul; 42(1):41-8. PubMed ID: 10394047
[TBL] [Abstract][Full Text] [Related]
17. Cerebral involvement in systemic lupus erythematosus.
Volkow ND; Warner N; McIntyre R; Valentine A; Kulkarni M; Mullani N; Gould L
Am J Physiol Imaging; 1988; 3(2):91-8. PubMed ID: 3260788
[TBL] [Abstract][Full Text] [Related]
18. [Central nervous system involvement in systemic lupus erythematosus].
Zhang X; Dong Y; Tang F; Li H; Zhang F
Zhonghua Nei Ke Za Zhi; 1999 Oct; 38(10):681-4. PubMed ID: 11798707
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of systemic lupus erythematosus (SLE) involving the central nervous system by magnetic resonance imaging (MRI)].
Suzuki K; Hara M; Nakajima S; Hirose T; Kitani A; Norioka K; Harigai M; Kawakami M; Tabata H; Kawagoe M
Ryumachi; 1989 Apr; 29(2):88-96. PubMed ID: 2772757
[TBL] [Abstract][Full Text] [Related]
20. Cerebral lesions in systemic lupus erythematosus detected by magnetic resonance imaging. Relationship to anticardiolipin antibody.
Ishikawa O; Ohnishi K; Miyachi Y; Ishizaka H
J Rheumatol; 1994 Jan; 21(1):87-90. PubMed ID: 8151596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
